Compound ID | 1514
Teicoplanin intermediate dicarbamate derivative (Analogue 4)
Class: Glycopeptide
| Spectrum of activity: | Gram-positive |
| Details of activity: | Inhibits cell wall biosynthesis by binding Lipid II. Exhibits activity against Gram positive bacteria, such as B. subtilis, MRSA, S. epidermidis and E. faecaelis |
| Institute where first reported: | University of Debrecen, Hungary |
| Year first mentioned: | 2020 |
| Highest developmental phase: | Preclinical |
| External links: | |
| Citation: | https://www.nature.com/articles/s41429-020-0313-6 |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.